Madison Bittner
4PUBLICATIONS
33CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 27, 2026
Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on KRAS/NF1 Mutational Status.Madison Bittner, Marta Llaurado Fernandez, Joshua Hoenisch
|Mar 28, 2025
FOLR1 as a therapeutic target in platinum-resistant ovarian carcinoma: unique expression patterns across ovarian carcinoma histotypes and molecular subtypes of low-grade serous carcinoma.Yuen Yee Leung, Marta Llaurado-Fernandez, Anna Cameron
|Oct 05, 2022
NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition.Marta Llaurado Fernandez, E Marielle Hijmans, Annemiek M C Gennissen
|Jun 29, 2022
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression.Dane Cheasley, Marta Llaurado Fernandez, Martin Köbel
Pageof 1
Frequent Collaborators
3 joint publications
Mark S Carey
3 joint publications
Nelson K Y Wong
2 joint publications
Martin Köbel
2 joint publications
Marta Llaurado-Fernandez
2 joint publications
Yuen Yee Leung
2 joint publications
Hannah Kim
2 joint publications
Amy Dawson
2 joint publications
Joshua Hoenisch
1 joint publications
Stephane Le Bihan
1 joint publications
E Marielle Hijmans
